$OSS
ONE STOP SYSTEMS, INC.

2023 Q2 Form 10-Q Financial Statement

#000095017023021209 Filed on May 11, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1 2022 Q1
Revenue $17.21M $16.78M $17.05M
YoY Change -5.97% -1.59% 28.06%
Cost Of Revenue $12.41M $11.71M $11.91M
YoY Change -5.26% -1.69% 34.1%
Gross Profit $4.798M $5.071M $5.141M
YoY Change -7.74% -1.36% 15.97%
Gross Profit Margin 27.88% 30.22% 30.15%
Selling, General & Admin $3.073M $2.285M $1.775M
YoY Change 68.71% 28.76% -17.75%
% of Gross Profit 64.05% 45.06% 34.52%
Research & Development $954.7K $1.195M $1.244M
YoY Change -23.75% -3.92% 49.49%
% of Gross Profit 19.9% 23.57% 24.2%
Depreciation & Amortization $270.3K $256.5K $254.0K
YoY Change 6.22% 0.98% 17.11%
% of Gross Profit 5.63% 5.06% 4.94%
Operating Expenses $8.211M $5.267M $4.491M
YoY Change 71.13% 17.29% 8.0%
Operating Profit -$3.414M -$196.3K $650.1K
YoY Change -949.31% -130.2% 136.38%
Interest Expense $23.94K $32.71K $58.72K
YoY Change -46.74% -44.3% -60.85%
% of Operating Profit 9.03%
Other Income/Expense, Net $1.411M $57.34K $94.41K
YoY Change 21983.64% -39.27% -154.47%
Pretax Income -$2.003M -$139.0K $744.5K
YoY Change -590.47% -118.67% 631.95%
Income Tax $396.9K $261.5K $165.3K
% Of Pretax Income 22.2%
Net Earnings -$2.399M -$400.5K $579.2K
YoY Change -843.29% -169.15% 1305.98%
Net Earnings / Revenue -13.94% -2.39% 3.4%
Basic Earnings Per Share -$0.12 -$0.02 $0.03
Diluted Earnings Per Share -$0.12 -$0.02 $0.03
COMMON SHARES
Basic Shares Outstanding 20.36M 20.36M 18.89M
Diluted Shares Outstanding 20.40M 20.25M 19.76M

Balance Sheet

Concept 2023 Q2 2023 Q1 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $15.42M $12.69M $15.76M
YoY Change 7.18% -19.49% -19.63%
Cash & Equivalents $6.100M $3.470M $2.220M
Short-Term Investments $9.321M $9.219M $13.54M
Other Short-Term Assets $1.232M $1.445M $1.055M
YoY Change 12.92% 36.91% 18.56%
Inventory $21.46M $23.64M $16.43M
Prepaid Expenses
Receivables $9.225M $10.11M $9.077M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $47.34M $47.88M $42.32M
YoY Change 3.01% 13.14% 18.25%
LONG-TERM ASSETS
Property, Plant & Equipment $2.433M $2.445M $2.870M
YoY Change -9.47% -14.81% -14.83%
Goodwill $4.421M $7.121M $7.121M
YoY Change -37.92% 0.0%
Intangibles $10.54K $26.35K $89.58K
YoY Change -85.71% -70.59%
Long-Term Investments
YoY Change
Other Assets $48.09K $60.24K $3.604M
YoY Change -98.69% -98.33% -2.06%
Total Long-Term Assets $7.481M $10.27M $14.77M
YoY Change -48.42% -30.47% 0.66%
TOTAL ASSETS
Total Short-Term Assets $47.34M $47.88M $42.32M
Total Long-Term Assets $7.481M $10.27M $14.77M
Total Assets $54.82M $58.15M $57.09M
YoY Change -9.33% 1.86% 13.14%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.811M $5.726M $4.393M
YoY Change -55.61% 30.34% 60.34%
Accrued Expenses $5.014M $3.591M $2.966M
YoY Change 67.5% 21.07% 47.55%
Deferred Revenue $287.0K $401.2K
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $3.013M $2.996M $2.219M
YoY Change 5.1% 35.02% -39.97%
Total Short-Term Liabilities $11.40M $13.12M $10.88M
YoY Change -12.66% 20.68% 10.42%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $207.5K $0.00
YoY Change -100.0% -100.0%
Other Long-Term Liabilities $148.8K $257.7K $794.4K
YoY Change -76.76% -67.56%
Total Long-Term Liabilities $148.8K $207.5K $794.4K
YoY Change -81.31% -73.89% -51.43%
TOTAL LIABILITIES
Total Short-Term Liabilities $11.40M $13.12M $10.88M
Total Long-Term Liabilities $148.8K $207.5K $794.4K
Total Liabilities $11.68M $13.73M $11.67M
YoY Change -19.35% 17.63% 1.57%
SHAREHOLDERS EQUITY
Retained Earnings -$4.503M -$2.103M $1.106M
YoY Change -415.18% -290.2%
Common Stock $2.053K $2.035K $1.991K
YoY Change 2.6% 2.21%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $43.14M $44.42M $45.42M
YoY Change
Total Liabilities & Shareholders Equity $54.82M $58.15M $57.09M
YoY Change -9.33% 1.86% 13.14%

Cashflow Statement

Concept 2023 Q2 2023 Q1 2022 Q1
OPERATING ACTIVITIES
Net Income -$2.399M -$400.5K $579.2K
YoY Change -843.29% -169.15% 1305.98%
Depreciation, Depletion And Amortization $270.3K $256.5K $254.0K
YoY Change 6.22% 0.98% 17.11%
Cash From Operating Activities $2.025M $23.96K -$5.018M
YoY Change -179.16% -100.48% -216.95%
INVESTING ACTIVITIES
Capital Expenditures $214.8K $85.09K $85.84K
YoY Change -484.6% -0.88% -29.5%
Acquisitions
YoY Change
Other Investing Activities -$115.7K $918.6K $1.114M
YoY Change -106.07% -17.57%
Cash From Investing Activities -$330.5K $833.5K $1.029M
YoY Change -117.86% -18.96% -944.7%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 939.5K -525.9K 1.131M
YoY Change -36.65% -146.49% -87.67%
NET CHANGE
Cash From Operating Activities 2.025M 23.96K -5.018M
Cash From Investing Activities -330.5K 833.5K 1.029M
Cash From Financing Activities 939.5K -525.9K 1.131M
Net Change In Cash 2.634M 331.6K 1.131M
YoY Change 239.76% -70.69% -91.52%
FREE CASH FLOW
Cash From Operating Activities $2.025M $23.96K -$5.018M
Capital Expenditures $214.8K $85.09K $85.84K
Free Cash Flow $1.810M -$61.12K -$5.104M
YoY Change -172.35% -98.8% -222.42%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001394056
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
001-38371
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
One Stop Systems, Inc.
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
33-0885351
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
2235 Enterprise Street #110
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Escondido
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92029
CY2023Q1 dei City Area Code
CityAreaCode
760
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
745-9883
CY2023Q1 dei Security12b Title
Security12bTitle
Common Stock, $0.0001 par value per share
CY2023Q1 dei Trading Symbol
TradingSymbol
OSS
CY2023Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2023Q1 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
20359119
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3470061
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3112196
CY2023Q1 us-gaap Short Term Investments
ShortTermInvestments
9218870
CY2022Q4 us-gaap Short Term Investments
ShortTermInvestments
10123535
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
10107413
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
11327244
CY2023Q1 us-gaap Inventory Net
InventoryNet
23642494
CY2022Q4 us-gaap Inventory Net
InventoryNet
20775366
CY2023Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1444681
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
502156
CY2023Q1 us-gaap Assets Current
AssetsCurrent
47883519
CY2022Q4 us-gaap Assets Current
AssetsCurrent
45840497
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2445005
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2570124
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
615639
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
731043
CY2023Q1 oss Deposits And Other Noncurrent
DepositsAndOtherNoncurrent
60243
CY2022Q4 oss Deposits And Other Noncurrent
DepositsAndOtherNoncurrent
60243
CY2023Q1 us-gaap Goodwill
Goodwill
7120510
CY2022Q4 us-gaap Goodwill
Goodwill
7120510
CY2023Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
26346
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
42154
CY2023Q1 us-gaap Assets
Assets
58151262
CY2022Q4 us-gaap Assets
Assets
56364571
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
5726202
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
4592713
CY2023Q1 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
3861398
CY2022Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
3013869
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
541177
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
536588
CY2023Q1 us-gaap Notes Payable Current
NotesPayableCurrent
2996157
CY2022Q4 us-gaap Notes Payable Current
NotesPayableCurrent
2952447
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
13124934
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
11095617
CY2023Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
207452
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
409294
CY2023Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
137215
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
138662
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
257714
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
397249
CY2023Q1 us-gaap Liabilities
Liabilities
13727315
CY2022Q4 us-gaap Liabilities
Liabilities
12040822
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
20359119
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
20359119
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
20084528
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
20084528
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
2035
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
2008
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
45661455
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
45513807
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
863520
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
510485
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2103063
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1702551
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
44423947
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
44323749
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
58151262
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
56364571
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
16781894
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
17052677
CY2023Q1 us-gaap Cost Of Revenue
CostOfRevenue
11711132
CY2022Q1 us-gaap Cost Of Revenue
CostOfRevenue
11912022
CY2023Q1 us-gaap Gross Profit
GrossProfit
5070762
CY2022Q1 us-gaap Gross Profit
GrossProfit
5140655
CY2023Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2285101
CY2022Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1774689
CY2023Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1786681
CY2022Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1471720
CY2023Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1195328
CY2022Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1244115
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
5267110
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
4490524
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-196348
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
650131
CY2023Q1 oss Nonoperating Interest Income
NonoperatingInterestIncome
110266
CY2022Q1 oss Nonoperating Interest Income
NonoperatingInterestIncome
51005
CY2023Q1 us-gaap Interest Expense
InterestExpense
32705
CY2022Q1 us-gaap Interest Expense
InterestExpense
58715
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-20223
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
102121
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
57338
CY2022Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
94411
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-139010
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
744542
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
261502
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
165308
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-400512
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
579234
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.03
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.02
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.03
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20251509
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
18886939
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20251509
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19764069
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-400512
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
579234
CY2023Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
13945
CY2022Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-5996
CY2023Q1 oss Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Including Forward Contract Gain Loss Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentIncludingForwardContractGainLossNetOfTax
339090
CY2022Q1 oss Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Including Forward Contract Gain Loss Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentIncludingForwardContractGainLossNetOfTax
-50366
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
353035
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-56362
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-47477
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
522872
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
44323749
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
474209
CY2023Q1 oss Adjustments To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net1
AdjustmentsToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet1
-326534
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
339090
CY2023Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
13945
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-400512
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
44423947
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
41958716
CY2022Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
382828
CY2022Q1 oss Stock Issued During Period Value Exercise Of Stock Options Restricted Stock Units And Warrants
StockIssuedDuringPeriodValueExerciseOfStockOptionsRestrictedStockUnitsAndWarrants
29670
CY2022Q1 oss Adjustments To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net1
AdjustmentsToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet1
-20478
CY2022Q1 oss Conversion Of Senior Secured Convertible Debt To Equity
ConversionOfSeniorSecuredConvertibleDebtToEquity
2590909
CY2022Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-50366
CY2022Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-5996
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
579234
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
45419984
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-400512
CY2022Q1 us-gaap Profit Loss
ProfitLoss
579234
CY2022Q1 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
71370
CY2022Q1 us-gaap Gain Loss On Disposition Of Intangible Assets
GainLossOnDispositionOfIntangibleAssets
-125000
CY2023Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
43243
CY2022Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-48861
CY2023Q1 oss Provision For Recovery Of Doubtful Accounts
ProvisionForRecoveryOfDoubtfulAccounts
30000
CY2022Q1 oss Provision For Recovery Of Doubtful Accounts
ProvisionForRecoveryOfDoubtfulAccounts
-5524
CY2023Q1 oss Warranty Reserve Adjustments
WarrantyReserveAdjustments
-591
CY2022Q1 oss Warranty Reserve Adjustments
WarrantyReserveAdjustments
14929
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
15808
CY2022Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
15809
CY2023Q1 us-gaap Depreciation
Depreciation
256465
CY2022Q1 us-gaap Depreciation
Depreciation
253982
CY2023Q1 us-gaap Inventory Lifo Reserve Period Charge
InventoryLIFOReservePeriodCharge
173970
CY2022Q1 us-gaap Inventory Lifo Reserve Period Charge
InventoryLIFOReservePeriodCharge
19342
CY2022Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1224
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
474209
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
382828
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1628801
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
4010998
CY2023Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
2909978
CY2022Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
4329659
CY2023Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
938797
CY2022Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
466400
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1097691
CY2022Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
2354165
CY2023Q1 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
638959
CY2022Q1 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
207297
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
23964
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-5018398
CY2023Q1 oss Redemption Of Short Term Investment Grade Securities
RedemptionOfShortTermInvestmentGradeSecurities
918609
CY2022Q1 oss Redemption Of Short Term Investment Grade Securities
RedemptionOfShortTermInvestmentGradeSecurities
989345
CY2022Q1 us-gaap Proceeds From Sale Of Intangible Assets
ProceedsFromSaleOfIntangibleAssets
125000
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
85085
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
85841
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
833524
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
1028504
CY2022Q1 oss Proceeds From Exercise Of Stock Options And Warrants
ProceedsFromExerciseOfStockOptionsAndWarrants
29670
CY2023Q1 oss Payment Of Payroll Taxes On Net Issuance Of Employee Stock Options
PaymentOfPayrollTaxesOnNetIssuanceOfEmployeeStockOptions
326534
CY2022Q1 oss Payment Of Payroll Taxes On Net Issuance Of Employee Stock Options
PaymentOfPayrollTaxesOnNetIssuanceOfEmployeeStockOptions
20478
CY2022Q1 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
2219128
CY2023Q1 us-gaap Repayments Of Medium Term Notes
RepaymentsOfMediumTermNotes
199399
CY2022Q1 us-gaap Repayments Of Medium Term Notes
RepaymentsOfMediumTermNotes
1096975
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-525933
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1131345
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
331555
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-2858549
CY2023Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
26310
CY2022Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-22825
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
3112196
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
5101174
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
3470061
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2219800
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
32705
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
6162
CY2023Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
21171
CY2022Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
25628
CY2022Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
1203580
CY2022Q1 us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
1477419
CY2022Q1 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
2590909
CY2023Q1 oss Reclassification Of Inventories To Property And Equipment
ReclassificationOfInventoriesToPropertyAndEquipment
25797
CY2022Q1 oss Reclassification Of Inventories To Property And Equipment
ReclassificationOfInventoriesToPropertyAndEquipment
61815
CY2023Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(33,37,41,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Use of Estimates</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(33,37,41,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent liabilities at the date of the condensed consolidated financial statements, and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from these estimates and assumptions.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(33,37,41,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">On an ongoing basis, our management evaluates these estimates and assumptions, including those related to determination of standalone selling prices of our products and services, allowance for doubtful account and sales reserves, income tax valuations, stock-based compensation, goodwill, intangible assets and inventory valuations and recoverability. We base our estimates on historical data and experience, as well as various other factors that our management believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(33,37,41,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Due to the COVID-19 pandemic, Ukraine war, inflationary pressures, other macroeconomic factors and reduced revenue opportunities with our largest customer there has been uncertainty and disruption in the global economy, financial markets and our ongoing operations. </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We are not aware of any specific event or circumstance that would require an update to our estimates or assumptions or a revision of the carrying value of our assets or liabilities as of the date of this Quarterly Report. These estimates and assumptions may change as new events occur and additional information is obtained. As a result, actual results could differ materially from these estimates and assumptions.</span></p>
CY2023Q1 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
137569
CY2022Q1 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
161535
CY2023Q1 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
10183241
CY2022Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
11372598
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
75828
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
45354
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
10107413
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
11327244
CY2023Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
30000
CY2022Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-5524
CY2023Q1 us-gaap Inventory Raw Materials
InventoryRawMaterials
11566008
CY2022Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
9370162
CY2023Q1 us-gaap Other Inventories Spare Parts
OtherInventoriesSpareParts
884680
CY2022Q4 us-gaap Other Inventories Spare Parts
OtherInventoriesSpareParts
892123
CY2023Q1 us-gaap Inventory Work In Process
InventoryWorkInProcess
754094
CY2022Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
1343239
CY2023Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
11730937
CY2022Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
10357452
CY2023Q1 us-gaap Inventory Gross
InventoryGross
24935719
CY2022Q4 us-gaap Inventory Gross
InventoryGross
21962976
CY2023Q1 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
1293225
CY2022Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
1187610
CY2023Q1 us-gaap Inventory Net
InventoryNet
23642494
CY2022Q4 us-gaap Inventory Net
InventoryNet
20775366
CY2023Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
3538793
CY2023Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
3512447
CY2023Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
26346
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
3538793
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
3496639
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
42154
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
15808
CY2022Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
15809
CY2023Q1 us-gaap Workers Compensation Liability Current
WorkersCompensationLiabilityCurrent
1226051
CY2022Q4 us-gaap Workers Compensation Liability Current
WorkersCompensationLiabilityCurrent
989478
CY2023Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
401192
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
378952
CY2023Q1 oss Customer Deposits
CustomerDeposits
410598
CY2022Q4 oss Customer Deposits
CustomerDeposits
61696
CY2023Q1 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
589830
CY2022Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
584268
CY2023Q1 us-gaap Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
406987
CY2022Q4 us-gaap Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
225743
CY2023Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
826740
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
773732
CY2023Q1 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
3861398
CY2022Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
3013869
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
2996157
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
207452
CY2023Q1 us-gaap Long Term Debt
LongTermDebt
3203609
CY2023Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
2996157
CY2023Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
207452
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2023Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
137569
CY2022Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
160910
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2023Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
0
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
474209
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
382828
CY2023Q1 us-gaap Lease Cost
LeaseCost
137569
CY2022Q1 us-gaap Lease Cost
LeaseCost
160910
CY2023Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P17M15D
CY2022Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P32M
CY2023Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.127
CY2022Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.123
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
445270
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
412433
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
857703
CY2023Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
58812
CY2023Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
798891
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
541177
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
257714
CY2023Q1 us-gaap Long Term Purchase Commitment Description
LongTermPurchaseCommitmentDescription
In the normal course of business, the Company may enter into purchase commitments for inventory components to be delivered based upon non-cancellable, pre-established, delivery schedules that are over a period that may exceed one year.
CY2023Q1 us-gaap Long Term Purchase Commitment Amount
LongTermPurchaseCommitmentAmount
12095680
CY2022Q1 oss Number Of Customers More Than Ten Percentage Of Revenue
NumberOfCustomersMoreThanTenPercentageOfRevenue
1
CY2023Q1 oss Number Of Customers More Than Ten Percentage Of Revenue
NumberOfCustomersMoreThanTenPercentageOfRevenue
1
CY2023Q1 oss Number Of Customers More Than Ten Percentage Of Net Trade Accounts Receivable
NumberOfCustomersMoreThanTenPercentageOfNetTradeAccountsReceivable
1
CY2022Q4 oss Number Of Customers More Than Ten Percentage Of Net Trade Accounts Receivable
NumberOfCustomersMoreThanTenPercentageOfNetTradeAccountsReceivable
2
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-400512
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
579234
CY2023Q1 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
20251509
CY2022Q1 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
18886939
CY2022Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
877130
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20251509
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19764069
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.03
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.02
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.03
CY2023Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
16781894
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
17052677
CY2023Q1 us-gaap Cost Of Revenue
CostOfRevenue
11711132
CY2022Q1 us-gaap Cost Of Revenue
CostOfRevenue
11912022
CY2023Q1 us-gaap Gross Profit
GrossProfit
5070762
CY2022Q1 us-gaap Gross Profit
GrossProfit
5140655
CY2023Q1 oss Gross Profit Percentage
GrossProfitPercentage
0.302
CY2022Q1 oss Gross Profit Percentage
GrossProfitPercentage
0.301
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
5267110
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
4490524
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-196348
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
650131

Files In Submission

Name View Source Status
oss-20230331_def.xml Edgar Link unprocessable
oss-20230331_cal.xml Edgar Link unprocessable
0000950170-23-021209-index-headers.html Edgar Link pending
0000950170-23-021209-index.html Edgar Link pending
0000950170-23-021209.txt Edgar Link pending
0000950170-23-021209-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
oss-20230331.htm Edgar Link pending
oss-20230331.xsd Edgar Link pending
oss-ex31_1.htm Edgar Link pending
oss-ex31_2.htm Edgar Link pending
oss-ex32_1.htm Edgar Link pending
oss-ex32_2.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
oss-20230331_lab.xml Edgar Link unprocessable
oss-20230331_pre.xml Edgar Link unprocessable
oss-20230331_htm.xml Edgar Link completed
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending